WDR36 gene rarely causes glaucoma in Italian families

Article

The WDR36 gene sequence rarely causes primary open-angle glaucoma (POAG) in Italian families.

The WDR36 gene sequence rarely causes primary open-angle glaucoma (POAG) in Italian families, confirms a study published in the British Journal of Ophthalmology.

Dr Paolo Frezzotti et al., Department of Ophthalmology, University of Siena, Siena, Italy, conducted a study on 34 Italian families with POAG. Out of the families, 25 had high-tension glaucoma (HTG), 4 had juvenile open-angle glaucoma and 1 presented with normal tension glaucoma. Four families were affected by both HTG-POAG and juvenile open-angle glaucoma. The families were analysed by denaturing high-performance liquid chromatography in order to mutate the WDR36 gene.

The findings suggest the D658G allele pose a higher risk in the families than the EDR36 gene. Further investigation of Italian families is required to identify WDR36's role in the pathophysiology of POAG.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.